In naturalistic psychedelic use, group use is common and acceptable
Kevin Byrne, Spencer Lindsay, Nicholas Baker, Christian Schmutz, Ben Lewis
Journal of Psychedelic Studies June 19, 2023 DOI: 10.1556/2054.2023.00261 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Population | English-speaking adults who use classic psychedelics naturalistically |
| Keywords | Mental health Harm Modalities Naturalistic observation Clinical psychology Naturalism |
| Citations | 4 |
| Key findings | Solo psychedelic use was more common than group use for improving mental health and was associated with more subjective symptom improvement, but overall perceived mental health benefit did not differ between settings. |
Abstract
Abstract Background and aims Most modern modalities of psychedelic-assisted psychotherapy (PAP) aim to minimize harm and maximize support by utilizing close, formalized supervision for a single participant per session. However, these substances are used naturalistically in a wide variety of settings. Our goal was to evaluate the perceived benefits and harms of naturalistic psychedelic use in diverse settings, with and without guidance/supervision.
Methods: An anonymous survey was distributed over Internet forums to solicit responses from English-speaking adults, with questions regarding the setting and perceived mental health-related outcomes of classic psychedelics. Data were analyzed to compare effects of group versus solo setting on perceived outcomes.
Results: For the goal of improving mental health, use in a solo setting was more common than in a group setting (COR 0.37 (0.20–0.68), p = 0.03) and was associated with more subjective symptom improvement (COR 0.22 (0.11–0.42), p = 0.0002). However, there was no significant difference in perceived overall mental health benefit between use in group and solo settings ( p = 1). Subjective negative outcomes on mental health were rare and not associated more so with psychedelic use in any particular setting. A majority of naturalistic psychedelic use took place in an informal setting, with no significant difference between solo or group users (95% vs 91%, p = 0.3).
Conclusions: Naturalistic psychedelic users are as likely to report an overall positive outcome and no more likely to report adverse events in group settings than in solo settings. This supports further research into PAP in group settings.
Citations in the library
Cited by 4
- A Scoping Review of Research in Naturalistic Studies with Psychedelics. Journal of Psychoactive Drugs June 28, 2025
- Naturalistic psychedelic experiences and gender-based self-acceptance in transgender and gender-expansive people International Journal of Transgender Health March 19, 2025
- Harm reduction practises for users of psychedelic drugs: a scoping review. Harm Reduction Journal October 3, 2025
- Freedom of Recreation: A Critique of the Prohibition, Decriminalization, and Legal Regulation of Psychedelics for Recreational Use Contemporary Drug Problems August 28, 2025
Cites 19
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
and 14 more in the library